LLC FORT - state-of-the-art production of immunobiological products meeting current GMP quality standards
LLC FORT is a biopharmaceutical company specializing in the development, manufacturing and marketing of biological drugs. The main activities are focused on the creation and production of innovative essential drugs, namely vaccines for the prevention of socially significant infectious diseases, as well as a number of unique products in therapeutic areas of high demand, in particular, immunology, rheumatology, nephrology, and oncology.
FORT's manufacturing facilities are represented by a modern large-scale biotech enterprise that produces drugs of international standard. A new scientific industrial complex was opened in April 2014 in the Ryazan Region. It enjoys modern infrastructure that ensures full production cycle and is in line with international GMP requirements. With its own research and production division, FORT can carry out efficient import substitution by operating at advanced levels of biotechnology and concentrating its efforts on the most important tasks: Russia's pharmaceutical sovereignty, as well as increasing the affordability of modern, high-quality drugs to its population.
FORT's manufacturing facilities are represented by a modern large-scale biotech enterprise that produces drugs of international standard. A new scientific industrial complex was opened in April 2014 in the Ryazan Region. It enjoys modern infrastructure that ensures full production cycle and is in line with international GMP requirements. With its own research and production division, FORT can carry out efficient import substitution by operating at advanced levels of biotechnology and concentrating its efforts on the most important tasks: Russia's pharmaceutical sovereignty, as well as increasing the affordability of modern, high-quality drugs to its population.
